LOSS OF ALKALINE-PHOSPHATASE ACTIVITY IN MENINGIOMAS - A RAPID HISTOCHEMICAL TECHNIQUE INDICATING PROGRESSION-ASSOCIATED DELETION OF A PUTATIVE TUMOR-SUPPRESSOR GENE ON THE DISTAL PART OF THE SHORT ARM OF CHROMOSOME-1
I. Niedermayer et al., LOSS OF ALKALINE-PHOSPHATASE ACTIVITY IN MENINGIOMAS - A RAPID HISTOCHEMICAL TECHNIQUE INDICATING PROGRESSION-ASSOCIATED DELETION OF A PUTATIVE TUMOR-SUPPRESSOR GENE ON THE DISTAL PART OF THE SHORT ARM OF CHROMOSOME-1, Journal of neuropathology and experimental neurology, 56(8), 1997, pp. 879-886
Apart from defined histomorphologic features, increased Ki-67 indices
and various numeric and structural chromosome aberrations, meningiomas
of the intermediate (WHO grade II, atypical meningioma) and anaplasti
c type (WHO grade III) are cytogenetically distinguished from common-t
ype meningiomas (WHO grade I) by frequent loss of the distal part of t
he short arm of one chromosome 1 (1p-), which formerly proved to be an
independent predictor of shorter recurrence-free intervals. Histochem
ically, loss of alkaline phosphatase activity (ALPL, liver/bone/kidney
type, EC 3.1.3.1) was another frequent, specific finding in meningiom
as with signs of dedifferentiation. In a prospective study including 6
6 meningiomas, all common-type meningiomas except one case (18/19) wer
e reactive for ALPL, whereas 75% (30/39) of intermediate type and all
anaplastic meningiomas (8/8) showed loss of enzyme activity in large a
reas of the tumor. Exclusively, the ALPL negative phenotype was associ
ated with Ip loss (15/19). Our data suggest that ALPL, which is coded
as a single copy gene on chromosome 1p36.1-p34, is a useful marker enz
yme for the loss of a putative regulatory (tumor suppressor) gene on c
hromosome Ip, or that ALPL itself represents a new tumor suppressor ge
ne homozygously inactivated in meningiomas.